Credo Technology Group Holding Ltd · Technology
Paid for today, but breaks on a small cut — or only looks over-priced at a 9% discount rate.
At a 25.0% margin the price needs +23.8% 3y revenue CAGR against +55.7% consensus, a cushion of +16.6pt versus a 27.8pt correction cut. The cushion covers a flush but not the 27.8pt bust a high-exposure name must absorb, so it is fragile. Concentrated capex name; the consensus CAGR is exposed.
Breaks if: Wrong if the 27.8pt cut is too harsh (growth holds near 56%) and margin holds at 25%+; worse if margin settles below 25%, which turns the +16.6pt cushion negative.. We re-check this against analyst estimates every evening.
10 years, at a 25% margin analysts expect
+33.0%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
5 published targets
Linked to AMD, AMZN, GOOGL, MSFT, NVDA, TSM
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 53% of reported profit arrived as operating cash, so the analysts' margin stands. Two or more red flags: this name cannot come out on top, however large its cushion.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Nov 21, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price of the price sits 64% below the median published model ($275) and 58-68% below the whole spread ($235-$310), meaning the market is deliberately discounting a growth story every covering analyst still rates far higher.
The one question is whether triple-digit revenue growth persists past FY2027 or collapses toward the +16% the reverse-DCF needs; unit_volumes via segment-revenue history is wired and can track this quarter by quarter, but pricing and customer-mix effects are not testable with the available tools.
What the price refuses to pay for, and the full reconstruction, on the CRDO quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names